U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649720) titled 'NaviCam Patency Capsule to Verify Gastrointestinal Patency' on May 24.
Brief Summary: Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Intestinal Stricture
Crohn Disease
NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy
Abdominal Pain
Intervention:
DEVICE: NaviCam Patency Capsule
The NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency ...